Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-14

Clinical Trial Update: A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the long-term safety and efficacy of albiglutide in Japanese patients with Type 2 diabetes mellitus, in combination with oral antihyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albiglutide (albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2015-10-14